Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4779174
Max Phase: Preclinical
Molecular Formula: C45H67N5O13
Molecular Weight: 886.05
Molecule Type: Unknown
Associated Items:
ID: ALA4779174
Max Phase: Preclinical
Molecular Formula: C45H67N5O13
Molecular Weight: 886.05
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C[C@H](CCC(=O)OCCOCCOCCOCCOCCN=[N+]=[N-])[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](OC(=O)[C@H](CC(=O)O)NC(=O)c5ccc([N+](=O)[O-])cc5)CC[C@]4(C)[C@H]3CC[C@]12C
Standard InChI: InChI=1S/C45H67N5O13/c1-30(4-13-41(53)62-27-26-61-25-24-60-23-22-59-21-20-58-19-18-47-49-46)36-11-12-37-35-10-7-32-28-34(14-16-44(32,2)38(35)15-17-45(36,37)3)63-43(55)39(29-40(51)52)48-42(54)31-5-8-33(9-6-31)50(56)57/h5-6,8-9,30,32,34-39H,4,7,10-29H2,1-3H3,(H,48,54)(H,51,52)/t30-,32-,34-,35+,36-,37+,38+,39+,44+,45-/m1/s1
Standard InChI Key: AQXCEIDVOBVSFO-KRBZIYOXSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 886.05 | Molecular Weight (Monoisotopic): 885.4735 | AlogP: 7.07 | #Rotatable Bonds: 26 |
Polar Surface Area: 247.82 | Molecular Species: ACID | HBA: 13 | HBD: 2 |
#RO5 Violations: 3 | HBA (Lipinski): 18 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: -10.22 | CX Basic pKa: | CX LogP: 6.17 | CX LogD: 2.69 |
Aromatic Rings: 1 | Heavy Atoms: 63 | QED Weighted: 0.02 | Np Likeness Score: 0.67 |
1. Fu CW,Tsai HE,Chen WS,Chang TT,Chen CL,Hsiao PW,Li WS. (2021) Sialyltransferase Inhibitors Suppress Breast Cancer Metastasis., 64 (1.0): [PMID:33371679] [10.1021/acs.jmedchem.0c01477] |
Source(1):